Transaction · 0001231919-26-001158

Akkaraju Srinivas

AKKARAJU SRINIVAS, DIR, reported an open-market or private sale at ALUMIS INC. involving 48066.000000 shares for an estimated $507019.39. Reported holdings after the transaction were 4663735.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
ALMSALUMIS INC.
Trade date
Sep 08, 2026
Filing date
Sep 10, 2026
View on SEC Insider profile
Estimated value-$507kShares × reported price
Shares traded48.0k$10.55 per share
Holdings after4.66MIndirect · By Samsara BioCapital, L.P.
% of reported position traded1.02%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 4,711,801 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ALMS price since this filing

Daily closing prices, with the filing date and available return windows
ALMS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +178.8%1w ago -4.3%1d ago +14.7%
Returns since7d -21.0%30d -27.7%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001231919-26-001158
Common Stock
Transaction date
Sep 08, 2026
Filed Sep 10, 2026, 01:39 AM · 2d delay
Shares
48,066 sh
$10.55 per share
Estimated value
-$507k
Computed from shares × price
Holdings after
4,663,735 sh
Indirect · By Samsara BioCapital, L.P.
Filing-only score

+4 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $11.02 to $11.60, inclusive. The Reporting Person undertake…

  2. F2F3(2 footnotes)

    Shares are directly held by Samsara BioCapital LP. ("Samsara LP"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara LP. The Reporting Person disc…

  3. F4

    The sales and purchases on September 8, 2026 were matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 48,066 shares in the case of Samsara LP and 48,065 shares in th…

  4. F5

    The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $10.38 to $10.91, inclusive. The Reporting Person undertake to pr…

  5. F6

    The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $10.26 to $10.835, inclusive. The Reporting Person undertake…

Original filing · 0001231919-26-001158
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ALMS